Viral Kinetics of the Y448H HCV NS5B Polymerase Mutant in Patients Treated with the HCV Inhibitor Tegobuvir (GS-9190)

Karin S Ku^*, Derrick D Goodman, Andrew S Bae, Michael D Miller, Hongmei Mo and Evguenia S Svarovskaia

Gilead Sciences Inc., Foster City, CA, USA

^*Corresponding Author: Karin S Ku, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA, Fax: 650-522-5890 Email: